Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
PLoS One. 2011;6(8):e23204. doi: 10.1371/journal.pone.0023204. Epub 2011 Aug 11.
Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically harbour multiple haploid clones. The apparent number of clones observed in any single infection depends on the diversity of the polymorphic markers used for the analysis, and the relative abundance of rare clones, which frequently fail to be detected among PCR products derived from numerically dominant clones. However, minority clones are of clinical interest as they may harbour genes conferring drug resistance, leading to enhanced survival after treatment and the possibility of subsequent therapeutic failure. We deployed new generation sequencing to derive genome data for five non-propagated parasite isolates taken directly from 4 different patients treated for clinical malaria in a UK hospital. Analysis of depth of coverage and length of sequence intervals between paired reads identified both previously described and novel gene deletions and amplifications. Full-length sequence data was extracted for 6 loci considered to be under selection by antimalarial drugs, and both known and previously unknown amino acid substitutions were identified. Full mitochondrial genomes were extracted from the sequencing data for each isolate, and these are compared against a panel of polymorphic sites derived from published or unpublished but publicly available data. Finally, genome-wide analysis of clone multiplicity was performed, and the number of infecting parasite clones estimated for each isolate. Each patient harboured at least 3 clones of P. falciparum by this analysis, consistent with results obtained with conventional PCR analysis of polymorphic merozoite antigen loci. We conclude that genome sequencing of peripheral blood P. falciparum taken directly from malaria patients provides high quality data useful for drug resistance studies, genomic structural analyses and population genetics, and also robustly represents clonal multiplicity.
疟原虫(Plasmodium falciparum)的天然血期感染通常含有多个单倍体克隆。在任何单一感染中观察到的克隆数量显然取决于用于分析的多态性标记的多样性,以及稀有克隆的相对丰度,这些克隆在来自数量上占优势的克隆的 PCR 产物中经常无法检测到。然而,少数派克隆具有临床意义,因为它们可能含有赋予耐药性的基因,导致治疗后生存能力增强,并有可能随后治疗失败。我们使用新一代测序技术,从直接取自英国医院因临床疟疾接受治疗的 4 名不同患者的 5 个非传播寄生虫分离物中获得基因组数据。对覆盖深度和配对读取之间序列间隔长度的分析确定了先前描述和新的基因缺失和扩增。对被抗疟药物选择的 6 个被认为是目标的基因进行了全长序列数据提取,并确定了已知和以前未知的氨基酸取代。从每个分离物的测序数据中提取了完整的线粒体基因组,并将其与来自已发表或未发表但公开可用数据的一组多态性位点进行比较。最后,对克隆多样性进行了全基因组分析,并估计了每个分离物的感染寄生虫克隆数量。通过这种分析,每个患者至少携带 3 个疟原虫(Plasmodium falciparum)克隆,这与传统的多态性裂殖体抗原基因座的 PCR 分析结果一致。我们得出结论,直接从疟疾患者外周血中提取的疟原虫(Plasmodium falciparum)基因组测序提供了高质量的数据,可用于耐药性研究、基因组结构分析和群体遗传学,并且还能可靠地代表克隆多样性。